No article text was recorded for this version.
drug discovery latency
Version 1 of 120 papers21 conceptsfrozen 2026-10-04
Papers in this version
- Blog: Deep Learning Based Drug Screening for Novel Coronavirus 2019-nCov
- Blog: Artificial Intelligence for COVID-19 Drug Discovery and Vaccine Development
- Blog: Identifying Novel Drug Indications through Automated Reasoning
- Blog: Repurpose Open Data to Discover Therapeutics for COVID-19 using Deep Learning
- Blog: Multiscale interactome analysis coupled with off-target drug predictions reveals drug repurposing candidates for human coronavirus disease
- Blog: Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2
- Blog: Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
- Blog: The brief overview, antivirus and anti-SARS-CoV-2 activity, quantitative methods, and pharmacokinetics of cepharanthine: a potential small-molecule drug against COVID-19
- Blog: Demystifying Drug Repurposing Domain Comprehension with Knowledge Graph Embedding
- Blog: Development of complemented comprehensive networks for rapid screening of repurposable drugs applicable to new emerging disease outbreaks
- Blog: FDA-approved phensuximide inhibits RIPK1-dependent immunogenic cell death
- Blog: TeX-Graph: Coupled tensor-matrix knowledge-graph embedding for COVID-19 drug repurposing
- Blog: Introduction to the Special Track on Artificial Intelligence and COVID-19 (Abstract Reprint)
- Blog: Machine learning research towards combating COVID-19: Virus detection, spread prevention, and medical assistance
- Blog: A novel drug repurposing approach for non-small cell lung cancer using deep learning
- Blog: Chemical screening links disulfiram with cardiac protection after ischemic injury
- Blog: Language models for the prediction of SARS-CoV-2 inhibitors
- Blog: Integrative transcriptome analyses empower the anti-COVID-19 drug arsenal
- Blog: Repositioning linifanib as a potent anti-necroptosis agent for sepsis
- Blog: Scalable HPC & AI infrastructure for COVID-19 therapeutics
History & citation
Current · Permanent link
- This direction split from Accelerating Drug Repurposing with Automated Reasoning and AI (95% overlap)
Cite this direction
Latest version (a living page):
@misc{lacuna_drug_discovery_latency_115c751c,
title = {drug discovery latency},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/drug-discovery-latency/rdr_115c751c33e9440c8f4f7ac494e742ac},
note = {Latest version of a living research direction; cite a version for a fixed text. Accessed 2026-11-21},
}This exact version (version 1, frozen text):
@misc{lacuna_drug_discovery_latency_115c751c_v1,
title = {drug discovery latency},
author = {{Lacuna}},
howpublished = {Lacuna research direction},
year = {2026},
url = {https://lacuna.tiptreesystems.com/direction/drug-discovery-latency/rdr_115c751c33e9440c8f4f7ac494e742ac/v/1},
note = {Version 1, frozen 2026-10-04. Accessed 2026-11-21},
}